Thank you for your interest in the 2023 100 Physician Leaders to Know list. Nominations will be open through May 31, 2023.  

Thank you for your interest in the 2023 75 ASC Administrators to Know list. Nominations will be open through Jun. 1, 2023.  

Thank you for your interest in the 2023 50 ASC Company CEOs to Know list. Nominations will be open through Jul. 1, 2023.  

Thank you for your interest in the 2023 Rising Stars in ASC: Leaders Under Age 40 list. Nominations will be open through Aug. 1, 2023.  

Thank you for your interest in the 2023 Minimally Invasive Spine Products to Know list. Nominations will be open through Jun. 1, 2023.  

Thank you for your interest in the 2023 MIS Orthopedic Products to Know list. Nominations will be open through Mar. 15, 2023.  

Thank you for your interest in the 2023 Infection Control Products to Know list. Nominations will be open through May 15, 2023.  

Thank you for your interest in the 2023 75 Orthopedic-focused ASCs to Know list. Nominations will be open through Mar. 20, 2023.  

Thank you for your interest in the 2023 50 Spine-focused ASCs to Know list. Nominations will be open through Apr. 1, 2023.  

Thank you for your interest in the 2023 50 GI-focused ASCs to Know list. Nominations will be open through May 1, 2023.  

Thank you for your interest in the 2023 50 ASC Management and Development Companies to Watch in 2024 list. Nominations will be open through Sep. 1, 2023.  

Here are 530+ ASCs wtih total joint replacements in 2021 

Here are 525 ASCs wtih total joint replacements in 2021. 

Here are 100 minimally invasive orthopedic products to know in 2021. 

Becker's is thrilled to feature 38 foot and ankle surgeons to know in 2020.

Becker's is thrilled to feature 65 total knee replacement surgeons to know in 2020.

Total joint replacements are moving to the outpatient setting, with nearly 500 ASCs and surgical hospitals across the country including outpatient total knee and hip procedures.

Spinal technology is evolving rapidly around minimally invasive techniques to perform more precise, less disruptive procedures. Device companies big and small aim to advance the field through innovative implant materials, techniques and technology that will make procedures more precise and patient-specific.

Here are six thoughts on the evolution of Amsurg and its leader, Chris Holden.

The gastrointestinal space offers companies from every spectrum of the industry an opportunity to define their space and develop and sell a superior product.